One-year resource utilisation, costs and quality of life in patients with acute respiratory distress syndrome (ARDS): secondary analysis of a randomised controlled trial

TitreOne-year resource utilisation, costs and quality of life in patients with acute respiratory distress syndrome (ARDS): secondary analysis of a randomised controlled trial
Publication TypeJournal Article
Year of Publication2016
AuthorsMarti, J, Hall, P, Hamilton, P, Lamb, S, McCabe, C, Lall, R, Darbyshire, J, Young, D, Hulme, C
JournalJournal of Intensive Care
Volume4
Issue26
Date Published08/2016
URLhttp://jintensivecare.biomedcentral.com/articles/10.1186/s40560-016-0178-8http://link.springer.com/content/pdf/10.1186/s40560-016-0178-8
DOI10.1186/s40560-016-0178-8
ISSN2052-0492
Abstract

Background

The long-term economic and quality-of-life outcomes of patients admitted to intensive care unit (ICU) with acute respiratory distress syndrome are not well understood. In this study, we investigate 1-year costs, survival and quality of life following ICU admission in patients who required mechanical ventilation for acute respiratory distress syndrome.

Methods

Economic analysis of data collected alongside a UK-based multi-centre randomised, controlled trial, aimed at comparing high-frequency oscillatory ventilation with conventional mechanical ventilation. The study included 795 critically ill patients admitted to ICU. Hospital costs were assessed using daily data. Post-hospital healthcare costs, patient out-of-pocket expenses, lost earnings of survivors and their carers and health-related quality of life were assessed using follow-up surveys.

Results

The mean cost of initial ICU stay was £26,857 (95 % CI £25,222–£28,491), and the average daily cost in ICU was £1738 (CI £1667–£1810). Following hospital discharge, the average 1-year cost among survivors was £7523 (CI £5692–£9354). The mean societal cost at 1 year was £44,077 (£41,168–£46,985), and the total societal cost divided by the number of 1-year survivors was £90,206. Survivors reported significantly lower health-related quality of life than the age- and sex-matched reference population, and this difference was more marked in younger patients.

Conclusions

Given the high costs and low health-related quality of life identified, there is significant scope for further research aimed at improving care in this in-need patient group.

Short Titlej intensive care
Citation Key / SERVAL ID8252
Peer reviewRefereed

                         

IUMSP | www.iumsp.ch
Institut universitaire de médecine sociale et préventive
Route de la Corniche 10, 1010 Lausanne - Switzerland
+41 21 314 72 72 | dess.info@unisante.ch

Go to top